Press-release for stocks

Prices are updated after-hours

Phio Pharmaceuticals Presents Preclinical Study Showing PH-762 Induces Systemic Memory T Cell Mediators of Anti-Tumor Immunity
Published: 2023-04-17 (Crawled : 12:00) - investors.phiopharma.com
PHIO | News | $0.6709 -19.16% -23.7% 640K

| -83.83% | O: 10.3% H: 17.14% C: 7.42%
ph-762 cell pharmaceuticals preclinical study

Phio Pharmaceuticals Presents New Data Demonstrating PH-894 Enhances Activity of HER2-CAR-T Cells at ASGCT 2022
Published: 2022-05-16 (Crawled : 12:00) - investors.phiopharma.com
PHIO | News | $0.6709 -19.16% -23.7% 640K

| 21.17% | O: 3.49% H: 6.15% C: 0.3%
ph-894 ph94 her2- her2

| -67.45% | O: -5.88% H: 2.5% C: -8.75%
positive car-t her2+ t-cell her2- her2

Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
Published: 2021-03-01 (Crawled : 13:12) - investors.phiopharma.com
PHIO | News | $0.6709 -19.16% -23.7% 640K

| -70.98% | O: 11.54% H: 4.08% C: -3.45%
collaboration cancer t-cell announces collaboration immunotherapy

78%

22%

MTTR | News M | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.